ArticleThe Journal of infectious diseases2026
Influenza Vaccination Effectiveness Against Influenza-Associated Hospitalization in Children and the Effects of Repeated Vaccination.
Article in The Journal of infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
- Commented on by
Authors and funding
10 authors.
Funding
Abstract
backgroundGiven concerns that influenza vaccine effectiveness (VE) might differ with repeated annual vaccination, we estimated VE against influenza-associated hospitalization and assessed repeat vaccination effects.
methodsWe analyzed a test-negative design study conducted in 3 Hong Kong hospitals (October 2015 - July 2025), excluding the 2020/21 and 2021/22 seasons due to the absence of influenza circulation during the COVID-19 pandemic. Polymerase chain reaction testing was used to identify influenza virus infections. We used conditional logistic regression to estimate influenza VE overall, by influenza type/subtype, and by influenza vaccination status in the preceding year (repeat vaccination status).
resultsWe analyzed data on 34 237 children, among whom 5245 (15.3%) tested positive for influenza. VE against influenza-associated hospitalization was 57.2% (95% confidence interval [CI]: 52.3%, 61.6%), with subtype-specific VE estimates of 67.7% (95% CI: 61.8%, 72.7%) for A(H1N1)pdm09, 60.6% (95% CI: 50.8%, 68.5%) for influenza B, and 37.2% (95% CI: 24.7%, 47.6%) for A(H3N2). The overall ΔVE (repeated VE - current only VE) was -13.6% (95% CI: -33.2%, 3.2%), indicating lower VE among repeatedly vaccinated children.
conclusionsCurrent influenza vaccination programs provide substantial protection, but could be further improved by strategies that mitigate repeat vaccination effects, and further research is needed to identify such strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.